Stoke therapeutics executive sells over $14k in company stock By Investing.com
© Reuters. Stoke Therapeutics, Inc. (NASDAQ:) has reported a recent stock transaction involving one of its top executives. Jonathan Allan, ...
© Reuters. Stoke Therapeutics, Inc. (NASDAQ:) has reported a recent stock transaction involving one of its top executives. Jonathan Allan, ...
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Conference Call February 15, 2024 5:00 PM ET Company Participants Atabak Mokari - ...
© Reuters. On Wednesday, Stifel, a financial services firm, raised its price target for Viking Therapeutics (NASDAQ:) to $35 from ...
© Reuters. EMERYVILLE, Calif. - 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT), a clinical-stage genetic medicines company, announced today that it has ...
Dyne Therapeutics (NASDAQ:DYN) announces the pricing of an underwritten public offering of 17.15 million shares of its common stock at ...
Dr_Microbe/iStock via Getty Images Corcept Therapeutics (NASDAQ:CORT) plummeted 38% in after-hours trading on Friday after a loss in a patent ...
Michael Fischer Incannex Healthcare Inc. (NASDAQ:IXHL) is a developer of medicinal cannabinoid and psychedelic pharmaceutical product candidates. The company was ...
Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Tierney Saccavino - ...
© Reuters. CytomX Therapeutics (NASDAQ:), a company dedicated to the discovery and development of novel cancer medicines, has reported its ...
Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Vivian Wu - Director, ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.